Children and adolescents infected with severe acute respiratory syndrome coronavirus 2
(SARS-CoV-2) are predominantly asymptomatic or have mild symptoms compared with the …

Abstract Purpose of Review To review the spectrum of cardiac manifestations and
treatments of multisystem inflammatory syndrome in children (MIS-C) associated with …

Objective To provide guidance on the management of Multisystem Inflammatory Syndrome
in Children (MIS‐C), a condition characterized by fever, inflammation, and multiorgan …

Multisystem inflammatory syndrome in children (MIS-C) is a post-infectious immune-
mediated condition, seen 3–5 weeks after COVID-19. Maternal SARS-CoV-2 may potentially …

Although there are many hypotheses for the age-related difference in the severity of COVID-
19, differences in innate, adaptive and heterologous immunity, together with differences in …

Thromboembolism is a common and deadly consequence of COVID-19 infection for
hospitalized patients. Based on clinical evidence pre-dating the COVID-19 pandemic and …

Abstract Purpose of Review Different treatment approaches have been described for the
management of COVID-19-related multisystem inflammatory syndrome in children (MIS-C) …

Abstract Purpose of Review Due to the rapidly changing landscape of COVID-19, the
purpose of this review is to provide a concise and updated summary of pediatric COVID-19 …

A novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was identified in
Wuhan, China, in December 2019 causing a worldwide pandemic. Children were initially …

Background Multisystem inflammatory syndrome in children (MIS-C) is a newly recognized
condition affecting children with recent infection or exposure to coronavirus disease 2019 …